NuCana

$4.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.04 (+0.90%) Today

$0.00 (0.00%) As of 10:03 AM UTC after-hours

Why Robinhood?

You can buy or sell NuCana and other stocks, options, and ETFs commission-free!

About NCNA

NuCana Plc engages in the development of technology platform for the treatment of patients with cancer. Its Protide technology consists of acelarin, NUC-3373 and NUC-7738. The company was founded by Hugh S. Griffith and Christopher B. Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom. The listed name for NCNA is NuCana plc American Depositary Share.

CEO

Hugh Stephen Griffith

Employees

Headquarters

Edinburgh, Midlothian

Founded

1997

Market Cap

143.91M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

116.11K

High Today

$4.58

Low Today

$4.44

Open Price

$4.44

Volume

93.78K

52 Week High

$10.59

52 Week Low

$3.81

Collections

Analyst Ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

NCNA Earnings

-$0.32

-$0.21

-$0.11

$0.00

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Estimated

— per share

Actual

-$0.31 per share